Stock listing
Munich:3NK Alphamab Oncology Aktie
German listing (Munich) of Alphamab Oncology · home listing HKEX:9966
Follow Alphamab Oncology into a list and get an email when it puts out news.
Home listing price · HKEX:9966
$6.22 HKD -0.28 (-4.2%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, HKEX:9966
- Day range
- $6.19 – $6.51 HKDOct 30, 2026
- Volume
- 1.11M sharesOct 30, 2026
- Market cap
- $6.01B HKDAt the close on Oct 30, 2026 · price × 966.6M shares outstanding
- 52-week range
- $5.87 – $12.20 HKDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $9.61M HKDMedian day 1.06M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| HKEX:9966 · Home | $6.215 HKD | -0.275 (-4.2%) | 1,106,000 | $6.39 | $6.505 | $6.19 | $6.49 | Close on Oct 30, 2026 |
| Frankfurt:3NK | €0.69 EUR | -0.035 (-4.8%) | — | €0.69 | €0.69 | €0.69 | €0.725 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · HKEX:9966 · HKD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $6.215 | -0.275 | -4.2% | $6.39 | $6.505 | $6.19 | 1,106,000 | |
| $6.49 | -0.06 | -0.9% | $6.56 | $6.73 | $6.34 | 747,000 | |
| $6.55 | +0.09 | +1.4% | $6.44 | $6.78 | $6.43 | 878,000 | |
| $6.46 | -0.31 | -4.6% | $6.80 | $6.88 | $6.405 | 883,000 | |
| $6.77 | +0.14 | +2.1% | $7.28 | $7.28 | $6.565 | 1,395,000 | |
| $6.63 | +0.43 | +6.9% | $6.40 | $6.64 | $5.87 | 1,912,000 | |
| $6.20 | -1.07 | -14.7% | $7.02 | $7.02 | $6.195 | 3,490,000 | |
| $7.27 | +0.21 | +3.0% | $7.06 | $7.375 | $7.00 | 3,483,000 | |
| $7.06 | +0.16 | +2.3% | $6.90 | $7.215 | $6.86 | 1,143,000 | |
| $6.90 | +0.225 | +3.4% | $6.81 | $7.18 | $6.81 | 1,037,000 | |
| $6.675 | -0.245 | -3.5% | $6.915 | $6.915 | $6.62 | 2,168,000 | |
| $6.92 | -0.125 | -1.8% | $7.045 | $7.055 | $6.73 | 1,360,000 | |
| $7.045 | -0.135 | -1.9% | $7.03 | $7.115 | $6.815 | 945,000 | |
| $7.18 | -0.175 | -2.4% | $7.40 | $7.50 | $7.145 | 871,000 | |
| $7.355 | -0.185 | -2.5% | $7.515 | $7.515 | $7.16 | 1,543,000 | |
| $7.54 | -0.545 | -6.7% | $8.055 | $8.055 | $7.48 | 1,940,000 | |
| $8.085 | -0.295 | -3.5% | $8.355 | $8.355 | $8.035 | 549,000 | |
| $8.38 | -0.02 | -0.2% | $8.40 | $8.635 | $8.26 | 479,000 | |
| $8.40 | +0.095 | +1.1% | $8.35 | $8.49 | $8.10 | 518,000 | |
| $8.305 | -0.145 | -1.7% | $8.16 | $8.415 | $7.825 | 1,096,257 | |
| $8.45 | +0.40 | +5.0% | $8.10 | $8.49 | $8.10 | 1,433,000 | |
| $8.05 | +0.05 | +0.6% | $8.075 | $8.22 | $7.96 | 1,301,000 | |
| $8.00 | -0.335 | -4.0% | $8.345 | $8.345 | $7.90 | 645,258 | |
| $8.335 | +0.015 | +0.2% | $8.205 | $8.46 | $8.115 | 629,000 | |
| $8.32 | -0.24 | -2.8% | $8.26 | $8.45 | $8.215 | 664,000 | |
| $8.56 | +0.455 | +5.6% | $8.015 | $8.62 | $8.015 | 1,136,500 | |
| $8.105 | +0.025 | +0.3% | $8.13 | $8.33 | $7.91 | 1,066,000 | |
| $8.08 | +0.33 | +4.3% | $7.775 | $8.23 | $7.575 | 1,871,000 | |
| $7.75 | +0.08 | +1.0% | $7.865 | $7.995 | $7.60 | 1,396,000 | |
| $7.67 | -0.055 | -0.7% | $7.875 | $7.875 | $7.605 | 610,472 | |
| $7.725 | -0.16 | -2.0% | $7.805 | $7.805 | $7.56 | 794,528 | |
| $7.885 | -0.145 | -1.8% | $8.03 | $8.03 | $7.83 | 332,000 | |
| $8.03 | +0.06 | +0.8% | $7.965 | $8.075 | $7.805 | 721,258 | |
| $7.97 | -0.36 | -4.3% | $8.115 | $8.125 | $7.825 | 1,226,000 | |
| $8.33 | -0.12 | -1.4% | $8.305 | $8.40 | $8.12 | 841,000 | |
| $8.45 | +0.14 | +1.7% | $8.32 | $8.49 | $8.255 | 976,000 | |
| $8.31 | -0.295 | -3.4% | $8.505 | $8.56 | $8.31 | 1,182,000 | |
| $8.605 | -0.165 | -1.9% | $8.735 | $8.925 | $8.55 | 1,001,000 | |
| $8.77 | -0.09 | -1.0% | $8.90 | $9.15 | $8.735 | 434,000 | |
| $8.86 | +0.29 | +3.4% | $8.615 | $8.90 | $8.515 | 1,119,000 | |
| $8.57 | +0.14 | +1.7% | $8.45 | $8.82 | $8.30 | 1,502,000 | |
| $8.43 | -0.535 | -6.0% | $9.25 | $9.265 | $8.415 | 1,446,000 | |
| $8.965 | +0.295 | +3.4% | $8.78 | $9.385 | $8.40 | 3,070,500 | |
| $8.67 | -0.445 | -4.9% | $9.01 | $9.13 | $8.49 | 1,824,000 | |
| $9.115 | +0.66 | +7.8% | $8.55 | $9.20 | $8.55 | 2,630,000 | |
| $8.455 | +0.325 | +4.0% | $8.23 | $8.86 | $8.23 | 2,481,000 | |
| $8.13 | +0.005 | +0.1% | $8.23 | $8.28 | $8.00 | 776,000 | |
| $8.125 | -0.055 | -0.7% | $8.185 | $8.19 | $8.03 | 599,000 | |
| $8.18 | -0.165 | -2.0% | $8.315 | $8.32 | $8.05 | 887,000 | |
| $8.345 | +0.21 | +2.6% | $8.20 | $8.82 | $8.20 | 1,959,000 | |
| $8.135 | +0.07 | +0.9% | $8.015 | $8.45 | $8.00 | 1,382,000 | |
| $8.065 | -0.285 | -3.4% | $8.11 | $8.30 | $8.00 | 650,000 | |
| $8.35 | +0.20 | +2.5% | $8.15 | $8.35 | $7.96 | 1,057,000 | |
| $8.15 | -0.30 | -3.6% | $8.325 | $8.375 | $8.08 | 949,000 | |
| $8.45 | +0.01 | +0.1% | $8.36 | $8.555 | $8.26 | 700,000 | |
| $8.44 | -0.115 | -1.3% | $8.425 | $8.53 | $8.335 | 476,000 | |
| $8.555 | +0.065 | +0.8% | $8.46 | $8.895 | $8.46 | 1,370,000 | |
| $8.49 | +0.47 | +5.9% | $8.17 | $8.50 | $8.055 | 1,678,000 | |
| $8.02 | +0.25 | +3.2% | $7.775 | $8.12 | $7.775 | 713,000 | |
| $7.77 | -0.125 | -1.6% | $7.81 | $7.92 | $7.60 | 654,000 | |
| $7.895 | +0.235 | +3.1% | $7.895 | $8.06 | $7.84 | 693,000 | |
| $7.66 | +0.26 | +3.5% | $7.80 | $8.35 | $7.60 | 2,607,000 | |
| $7.40 | -0.07 | -0.9% | $7.56 | $7.56 | $7.28 | 1,164,000 | |
| $7.47 | -0.11 | -1.5% | $7.61 | $7.69 | $7.37 | 599,000 | |
| $7.58 | +0.02 | +0.3% | $7.56 | $7.63 | $7.38 | 885,000 |
- Ticker
- Munich:3NK
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Nov 2, 2026
Next Day Disclosure Return
Latest news
Supplementary announcement on discloseable transaction
Oct 29, 2026
Closed $6.22 (-4.2%) on Oct 30, 2026
Voluntary announcement - first patient dosed in phase iii clinical study of JSKN033 monotherapy for the treatment of cervical cancer
Oct 28, 2026
Closed $6.49 (-0.9%) on Oct 29, 2026
Grant of award shares under the restricted share award scheme
Oct 27, 2026
Closed $6.55 (+1.4%) on Oct 28, 2026
Voluntary announcement - latest research updates of JSKN003 presented at the 2026 esmo congress
Oct 26, 2026
Closed $6.46 (-4.6%) on Oct 27, 2026
Voluntary announcement - results of a phase i/ii clinical study of JSKN033 in patients with cc following failure of standard treatment were presented at the 2026 esmo congress as a rapid oral presentation
Oct 26, 2026
Closed $6.77 (+2.1%) on Oct 26, 2026
Voluntary announcement - latest research results of two phase iii clinical studies of anbenitamab (KN026) were presented at the 2026 esmo congress as lba oral presentations
Oct 26, 2026
Closed $6.77 (+2.1%) on Oct 26, 2026
Discloseable transaction - exercise of warrant to subscribe for preferred stock of pathos AI, inc.
Oct 23, 2026
Closed $6.77 (+2.1%) on Oct 26, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Oct 5, 2026
Closed $8.38 (-0.2%) on Oct 6, 2026
Alphamab Oncology on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 32 in the last 12 months · 58 in all · newest Nov 2, 2026 · oldest 2020
Where Alphamab Oncology is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| HKEX:9966 康寧傑瑞製藥 · Home listing | HKEX | Hong Kong | HKD |
| LS Exchange:A2PWDV | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2PWDV | Lang & Schwarz | Germany | EUR |
| gettex:3NK | gettex | Germany | EUR |
| Dusseldorf:3NK | Dusseldorf | Germany | EUR |
| Frankfurt:3NK | Frankfurt | Germany | EUR |
| Munich:3NK · This page | Munich | Germany | EUR |
| OTC:ALMOF | OTC | United States | USD |
| Stuttgart:3NK | Stuttgart | Germany | EUR |
| Tradegate:3NK | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Alphamab Oncology.